Jennifer Iaci

This inventor holds 23 USPTO granted patents and 11 published patent applications, plus 5 CIPO patents and 11 EPO patents, primarily in Neuroscience Therapeutics. Top assignee: Acorda Therapeutics, Inc.. Active years: 2009-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Iaci. Retrieved from https://idiyas.com/inventor/jennifer-iaci

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23 (Patent Applications = 11)

% Patents Active = 34.8

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 12)

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 24(Granted Patents)

Location History:

Montville, NY (US) (2009)
Montville, NJ (US) (2014)
Boonton, NY (US) (2020)
Boonton, NJ (US) (2010 - 2022)

Company Filing History:

23 out of 90

Acorda Therapeutics, Inc.

patents

Years Active: 2009-2022

Loading Chart...

Areas of Expertise:

Neuregulin

Heart Failure

CNS Injury

Chondroitinase ABCI

Neuronal Outgrowth

Fusion Proteins

Peripheral Nerve Injury

Therapeutic Dosing

Compositions

Methods

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11235031 - Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure (2022-02-01),

2. 10668131 - Compositions and methods for treatment during non-acute periods following CNS neurological injury (2020-06-02),

3. 10323240 - Compositions and methods of using chondroitinase ABCI mutants (2019-06-18),

4. 9987340 - Compositions and methods of using chondroitinase ABCI mutants (2018-06-05),

5. 9956273 - Compositions and methods for promoting neuronal outgrowth (2018-05-01),

6. 9956266 - Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure (2018-05-01),

7. 9834764 - Compositions and methods of using chondroitinase ABCI mutants (2017-12-05),

8. 9498515 - Compositions and methods for treatment during non-acute periods following CNS neurological injury (2016-11-22),

9. 9468671 - Compositions and methods for promoting neuronal outgrowth (2016-10-18),

10. 9410141 - Compositions and methods of using chondroitinase ABCI mutants (2016-08-09),

11. 9402886 - Compositions and methods of using chondroitinase ABCI mutants (2016-08-02),

12. 9198951 - Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure (2015-12-01),

13. 9102930 - Compositions and methods of using chondroitinase ABCI mutants (2015-08-11),

14. 9078861 - Use of a neuregulin to treat peripheral nerve injury (2015-07-14),

15. 8906363 - Fusion proteins for the treatment of CNS (2014-12-09),

Title: The Innovative Mind of Jennifer Iaci

Introduction: Jennifer Iaci, a talented inventor hailing from Boonton, NJ, is known for her groundbreaking contributions to the field of technology.

Latest Patents: Jennifer Iaci's most recent patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time.

Career Highlights: With a career spanning over two decades, Jennifer Iaci has consistently pushed the boundaries of innovation. Her work in developing sustainable energy solutions has earned her recognition as a pioneer in the green technology sector.

Collaborations: Jennifer Iaci has collaborated with leading research institutions and universities to further her inventions. Her partnerships with top engineers and scientists have resulted in the creation of patented technologies that have a lasting impact on society.

Conclusion: Jennifer Iaci's passion for innovation and dedication to creating a better future through her inventions make her a true trailblazer in the world of technology. Her relentless pursuit of excellence continues to inspire the next generation of inventors.

Profile summary based on public USPTO records.